About Meiogenix
Meiogenix is a company based in Paris (France) founded in 2010.. Meiogenix has raised $13 million across 3 funding rounds from investors including ARE, Bpifrance and Kurma Partners. Meiogenix offers products and services including Chromosome Editing. Meiogenix operates in a competitive market with competitors including GSK, Benson Hill, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
- Headquarter Paris, France
-
Sectors
HealthcareAgriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Meiogenix Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13 M (USD)
in 3 rounds
-
Latest Funding Round
$13 M (USD), Series A
Dec 14, 2021
-
Investors
ARE
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Meiogenix
Meiogenix offers a comprehensive portfolio of products and services, including Chromosome Editing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Edits crop chromosomes to unlock genetic diversity for addressing farming challenges.
Unlock access to complete
Unlock access to complete
Funding Insights of Meiogenix
Meiogenix has successfully raised a total of $13M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $13 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $13.0M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Series A - Meiogenix | Valuation | Sofinnova Partners | |
| Apr, 2016 | Amount | Grant - Meiogenix | Valuation |
investors |
|
| Nov, 2010 | Amount | Series A - Meiogenix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Meiogenix
Meiogenix has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Bpifrance and Kurma Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Founded Year | Domain | Location | |
|
Early-stage VC firm focused on life science startups
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Meiogenix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Meiogenix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Meiogenix Comparisons
Competitors of Meiogenix
Meiogenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Benson Hill, Avidity Biosciences, Sutro Biopharma and Antheia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Provider of plant-based food ingredients
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Meiogenix
Frequently Asked Questions about Meiogenix
When was Meiogenix founded?
Meiogenix was founded in 2010.
Where is Meiogenix located?
Meiogenix is headquartered in Paris, France.
Who is the current CEO of Meiogenix?
Luc Mathis is the current CEO of Meiogenix.
Is Meiogenix a funded company?
Meiogenix is a funded company, having raised a total of $13M across 3 funding rounds to date.
What does Meiogenix do?
Meiogenix was founded in 2010 and is based in Paris, France. Operations focus on the agricultural biotechnology sector, where novel breeding technologies for crop plants are developed. A fusion protein platform is utilized to enhance recombination rates in cold regions. Solutions aimed at improving crop resilience, quality, and yield are pursued through these technologies.
Who are the top competitors of Meiogenix?
Meiogenix's top competitors include Benson Hill, Sutro Biopharma and Cibus.
What products or services does Meiogenix offer?
Meiogenix offers Chromosome Editing.
Who are Meiogenix's investors?
Meiogenix has 6 investors. Key investors include ARE, Bpifrance, Kurma Partners, Sofinnova Partners, and Genoa Ventures.